View in EDS

KAT7 is a genetic vulnerability of acute myeloid leukemias driven by MLL rearrangements.

Saved in:
Bibliographic Details
Title: KAT7 is a genetic vulnerability of acute myeloid leukemias driven by MLL rearrangements.
Authors: Au YZ; Stem Cell Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK.; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK.; Dana-Farber Cancer Institute, Boston, MA, USA., Gu M; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK., De Braekeleer E; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK., Gozdecka M; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK.; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Aspris D; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK., Tarumoto Y; Stem Cell Genetics, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan., Cooper J; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK., Yu J; Stem Cell Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK.; Department of Cell Biology, The Francis Crick Institute, London, UK., Ong SH; Stem Cell Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK., Chen X; Gene Expression Genomics, Wellcome Sanger Institute, Hinxton, Cambridge, UK., Tzelepis K; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK.; Gurdon Institute, University of Cambridge, Tennis Court Road, Cambridge, UK., Huntly BJP; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, UK.; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK., Vassiliou G; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK. gsv20@sanger.ac.uk.; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK. gsv20@sanger.ac.uk.; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, UK. gsv20@sanger.ac.uk., Yusa K; Stem Cell Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK. k.yusa@infront.kyoto-u.ac.jp.; Stem Cell Genetics, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan. k.yusa@infront.kyoto-u.ac.jp.
Source: Leukemia [Leukemia] 2021 Apr; Vol. 35 (4), pp. 1012-1022. Date of Electronic Publication: 2020 Aug 06.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32764680
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: KAT7 is a genetic vulnerability of acute myeloid leukemias driven by MLL rearrangements.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Au+YZ%22">Au YZ</searchLink>; Stem Cell Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK.; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK.; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Gu+M%22">Gu M</searchLink>; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22De+Braekeleer+E%22">De Braekeleer E</searchLink>; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Gozdecka+M%22">Gozdecka M</searchLink>; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK.; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Aspris+D%22">Aspris D</searchLink>; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Tarumoto+Y%22">Tarumoto Y</searchLink>; Stem Cell Genetics, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.<br /><searchLink fieldCode="AU" term="%22Cooper+J%22">Cooper J</searchLink>; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Yu+J%22">Yu J</searchLink>; Stem Cell Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK.; Department of Cell Biology, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Ong+SH%22">Ong SH</searchLink>; Stem Cell Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Chen+X%22">Chen X</searchLink>; Gene Expression Genomics, Wellcome Sanger Institute, Hinxton, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Tzelepis+K%22">Tzelepis K</searchLink>; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK.; Gurdon Institute, University of Cambridge, Tennis Court Road, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Huntly+BJP%22">Huntly BJP</searchLink>; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, UK.; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Vassiliou+G%22">Vassiliou G</searchLink>; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK. gsv20@sanger.ac.uk.; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK. gsv20@sanger.ac.uk.; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, UK. gsv20@sanger.ac.uk.<br /><searchLink fieldCode="AU" term="%22Yusa+K%22">Yusa K</searchLink>; Stem Cell Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK. k.yusa@infront.kyoto-u.ac.jp.; Stem Cell Genetics, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan. k.yusa@infront.kyoto-u.ac.jp.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228704895%22">Leukemia</searchLink> [Leukemia] 2021 Apr; Vol. 35 (4), pp. 1012-1022. <i>Date of Electronic Publication: </i>2020 Aug 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%2C+Specialist+Journals%22">Nature Publishing Group, Specialist Journals </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8704895 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5551 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208876924%22">08876924 </searchLink><i>NLM ISO Abbreviation: </i>Leukemia <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32764680
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41375-020-1001-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1012
    Titles:
      – TitleFull: KAT7 is a genetic vulnerability of acute myeloid leukemias driven by MLL rearrangements.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Au YZ
      – PersonEntity:
          Name:
            NameFull: Gu M
      – PersonEntity:
          Name:
            NameFull: De Braekeleer E
      – PersonEntity:
          Name:
            NameFull: Gozdecka M
      – PersonEntity:
          Name:
            NameFull: Aspris D
      – PersonEntity:
          Name:
            NameFull: Tarumoto Y
      – PersonEntity:
          Name:
            NameFull: Cooper J
      – PersonEntity:
          Name:
            NameFull: Yu J
      – PersonEntity:
          Name:
            NameFull: Ong SH
      – PersonEntity:
          Name:
            NameFull: Chen X
      – PersonEntity:
          Name:
            NameFull: Tzelepis K
      – PersonEntity:
          Name:
            NameFull: Huntly BJP
      – PersonEntity:
          Name:
            NameFull: Vassiliou G
      – PersonEntity:
          Name:
            NameFull: Yusa K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2021 Apr
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1476-5551
          Numbering:
            – Type: volume
              Value: 35
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Leukemia
              Type: main
ResultId 1